Ebola Aid Workers to Test New Vaccine

GENEVA (AP) — The Swiss agency that regulates new drugs has approved the application for a clinical trial with an experimental Ebola vaccine at the Lausanne University Hospital.

Swissmedic says the trial will be conducted on 120 volunteer participants with support from the U.N. World Health Organization.

The agency said in a statement Tuesday that the trial continues a series that began in the United States, Britain and Mali, using a vaccine based on a genetically modified chimpanzee adenovirus.

The experimental vaccine is to be initially administered on healthy volunteers who will be sent as medical staff to fight the Ebola epidemic in West Africa.

(Copyright 2014, KRON 4 and the Associated Press, All rights reserved.)

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s